Inspection Readiness Is About Traceability, Not Documentation
Inspections have evolved. What matters most today isn’t the volume of documentation, but the clarity of oversight logic. What Inspectors Expect to Understand Inspectors increasingly focus on: Why certain risks were prioritized How oversight strategies were chosen What actions were taken when signals emerged How outcomes were verified This requires traceability, not reconstruction. RBQM Done […]
RBQM in Practice: From Principles to Proportionate Oversight
Regulatory guidance clearly defines what RBQM is intended to achieve. The harder question is how those principles translate into daily oversight decisions. This is where many RBQM programs struggle. CtQs Are Necessary—But Not Sufficient Critical-to-Quality (CtQ) factors anchor modern RBQM. They define what truly matters to participant safety and data reliability. But CtQs only create […]
What Sponsors Actually Look for in CRO RBQM
And why inspection readiness is now a commercial differentiator. RBQM is often discussed as a regulatory requirement. But for CROs, it has become something more. It’s now a factor in how Sponsors select partners, evaluate performance, and decide where to expand or reduce scope. Understanding what Sponsors are actually looking for requires looking beyond the […]
From Fragmentation to a Scalable RBQM Operating Model
Why tools alone aren’t enough, and what CROs need instead. Most CROs don’t lack RBQM capability. They have invested in centralized monitoring. They have access to data. They have systems that can surface signals and identify outliers across studies. And yet, execution remains inconsistent. The issue isn’t visibility. It’s coordination. Why Fragmentation Persists In many […]
Monitoring Isn’t a Cost Problem. It’s a Margin Lever.
Why CROs need to rethink monitoring, not reduce it. For years, the conversation around monitoring has been framed in terms of cost. How many visits are we doing? How much SDV is required? Where can we reduce effort without increasing risk? Those questions made sense in a model where monitoring focused primarily on coverage, ensuring […]
Why RBQM Fails at Scale in CROs
Most CROs don’t lack RBQM capabilities. They lack a model to execute it consistently. Most CROs today would say they’re doing RBQM. They have centralized monitoring in place. They track KRIs and QTLs. They review data regularly and can identify emerging risks across studies. From a capability standpoint, the foundation is in place. And yet, […]
ICH E6(R3), Demystified Part 4: Informed Consent
From Signature to System: Why E6(R3) Raises the Bar For years, informed consent has too often been treated as a regulatory artifact, a document to be signed, filed, and archived. ICH E6(R3) quietly but decisively challenges that mindset. The revision does not radically rewrite the rules of informed consent. Instead, it does something more powerful: it […]
Why RBQM Programs Stall: The Gap Between Insight and Action
Many organizations invest heavily in detection, analytics, dashboards, and centralized monitoring. Yet RBQM still stalls. The reason is not lack of insight.It is lack of structure between insight and action. Detection alone does not sustain oversight.Insight alone does not create consistency. RBQM becomes difficult to maintain when there is no defined way to translate signals […]
RBQM for the Mid-Market Explained
Mid-market sponsors are expected to meet the same ICH E6(R3) standards as large pharma, often with lean teams, heavy CRO reliance, and limited analytics support. The good news: modern RBQM doesn’t have to be complex or disruptive. The Mid-Market Reality Under ICH E6(R3) ICH E6(R3) has clarified something many mid-market organizations already feel: RBQM is no longer optional. Sponsors are expected to demonstrate proactive, CtQ-driven […]
5 Myths Mid-Market Teams Believe About RBQM and What ICH E6(R3) Actually Requires
Risk-Based Quality Management (RBQM) is no longer a future-state concept. Under ICH E6(R3), it is a clear regulatory expectation. Yet many mid-market sponsors still struggle to move from understanding RBQM to operationalizing it. The hesitation isn’t usually philosophical, it’s practical. Long-standing assumptions make RBQM feel complex, disruptive, or unrealistic for lean, CRO-dependent teams. The problem is that many of those assumptions are based on myths, not […]
